Clinical Trials in Mostar, Bosnia and Herzegovina
7 recruiting
Showing 1–7 of 7 trials
Recruiting
Phase 2
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
ColitisInflammatory Bowel DiseasesUlcerative Colitis+1 more
Spyre Therapeutics, Inc.645 enrolled126 locationsNCT07012395
Recruiting
Phase 3
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Radiological and Clinical Effects of Subcutaneous Ublituximab in Participants With Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis
TG Therapeutics, Inc.360 enrolled42 locationsNCT07211633
Recruiting
Phase 1
DR-0201 in Subjects With Autoimmune Diseases
SclerodermaSLEDermatomyositis+9 more
Dren Bio36 enrolled10 locationsNCT06647069
Recruiting
Phase 3
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
Non-Hodgkin LymphomaBacterial InfectionsHypogammaglobulinemia+2 more
Grifols Therapeutics LLC386 enrolled61 locationsNCT05645107
Recruiting
Phase 1
A Study of Aumolertinib in European Participants With Non-Small Cell Lung Cancer
Non-small Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.20 enrolled6 locationsNCT07130916
Recruiting
Phase 3
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
Hepatocellular CarcinomaCirrhosis
Can-Fite BioPharma471 enrolled32 locationsNCT05201404
Recruiting
Not Applicable
Feasibility Clinical Study of the Alma System in Treating Primary Postpartum Hemorrhage
Postpartum Haemorrhage (PPH)PPHPostpartum Hemorrhage (Primary)
ResQ Medical Ltd10 enrolled1 locationNCT06646653